Report cover image

Mobile Video Surveillance Market Share, Size, Trends, Industry Analysis Report, By Offering (Hardware, Software, and Service); By Application; By Vertical; By Region; Segment Forecast, 2023 - 2032

Published Sep 01, 2025
Length 115 Pages
SKU # PLRS20470439

Description

The global mobile video surveillance market size is expected to reach USD 6.19 billion by 2034, according to a new study by Polaris Market Research. The report “Mobile Video Surveillance Market Share, Size, Trends, Industry Analysis Report, By Offering (Hardware, Software, and Service), By Application, By Vertical, and By Region -Market Forecast, 2025-2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The exponential rise in the use of the internet and its related products across the globe along with the ubiquitous usage of smartphones and tablets, which significantly increases computational power is one of the primary key factors influencing the global market growth. In the last few years, mobile video surveillance has gained high traction and popularity as it enables video streaming wirelessly with the help of a camera to a control center.

A large number of key market players are involved in various development-related activities of innovative video surveillance techniques and solutions by heavily investing in their R&D is also likely to have a positive impact on the market growth over the coming years. For instance, in June 2022, Axis Communications announced the launch of its new next-generation AXIS M11 Box cameras that offers high image resolution even in low light conditions. These cameras include a CS mounted with the support for the motorized i-CS lenses & ensured great picture details.

There has been a significant rise in the adoption of remote or offsite management of security across various application areas including transportation, military & defense, law enforcement, and industrial among others, as these types of systems allow users to view and monitor remotely from almost anywhere on personal computers, tablets, and smartphones through a reliable internet connection. Due to these features, an extensively increasing number of government organizations and economic establishments are deploying these systems to protect them against fraud or terrorist activities.

Mobile Video Surveillance Market Report Highlights

Hardware segment accounted for considerable global market share in 2024 on account of changes in user preferences towards IP cameras and growing use of video encoders

Drones segment is anticipated to grow fastest during the forecast period owing to its numerous beneficial properties like performing army support, intelligence missions, and mountain search and rescue missions very effectively

Transportation segment held the highest market revenue share in 2024, which is mainly driven by an extensive rise in the number need for advanced surveillance due to an increase in activities like terrorism and vandalism

Asia Pacific region dominated the global market and accounted for a healthy market share in 2022 due to the continuous rise in the prevalence for smartphones and the trend of adopting video surveillance among small businesses

The global key market players include Axis Communications, Hanwha Techwin, Huawei Technologies, Infinova and United Technologies, and Bosch Security & Safety Systems

Polaris Market Research has segmented the mobile video surveillance market report based on offering, application, vertical, and region:

Mobile Video Surveillance, Offering Outlook (Revenue - USD Billion, 2020 - 2034)

Hardware

Software

Service

Mobile Video Surveillance, Application Outlook (Revenue - USD Billion, 2020 - 2034)

Railways

Buses

Transport Vehicles

Police Vehicles

Drones

Mobile Video Surveillance, Vertical Outlook (Revenue - USD Billion, 2020 - 2034)

Law Enforcement

Industrial

Commercial

Military & Defense

First Responders

Transportation

Mobile Video Surveillance, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

115 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights
4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Market Snapshot
4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Expenditure on Animal Health
4.2.1.2. Increasing Investment in Facility Expansion
4.2.2. Restraints and Challenges
4.2.2.1. Stringent Regulation
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
4.6. Value Chain Analysis
5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
5.3. In House
5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In House, by Region, 2020-2034 (USD Billion)
5.4. Contract Outsourcing
5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
5.4.2. Contract Development
5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
5.4.2.2. Preclinical Development
5.4.2.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
5.4.2.3. Clinical Development
5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
5.4.3. Contract Manufacturing
5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)
6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
6.3. Chemical-based API
6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
6.4. Biological API
6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
6.5. HPAPI
6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)
7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type
7.1. Key Findings
7.2. Introduction
7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
7.3. Production Animals
7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
7.4. Companion Animals
7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)
8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category
8.1. Key Findings
8.2. Introduction
8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
8.3. Antiparasitics
8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
8.4. Anti-infectives
8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
8.5. NSAIDs
8.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
8.6. Others
8.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography
9.1. Key Findings
9.2. Introduction
9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – North America
9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – US
9.3.5.1. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.3.5.2. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.3.5.3. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.3.5.4. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Canada
9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Europe
9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – UK
9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – France
9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Germany
9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Italy
9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Spain
9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Netherlands
9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Russia
9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.11.2. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Rest of Europe
9.4.12.1. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.4.12.2. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.4.12.3. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.4.12.4. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Asia Pacific
9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – China
9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.5.2. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – India
9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.6.2. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Malaysia
9.5.7.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.7.2. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.7.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.7.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Japan
9.5.8.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.8.2. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.8.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.8.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Indonesia
9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.9.2. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – South Korea
9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.10.2. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Australia
9.5.11.1. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.11.2. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.11.3. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.11.4. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Rest of Asia Pacific
9.5.12.1. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.5.12.2. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.5.12.3. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.5.12.4. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Middle East & Africa
9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Saudi Arabia
9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – UAE
9.6.6.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.6.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.6.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.6.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Israel
9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – South Africa
9.6.8.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.8.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.8.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.8.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Rest of Middle East & Africa
9.6.9.1. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.6.9.2. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.6.9.3. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.6.9.4. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Latin America
9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Mexico
9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Brazil
9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Argentina
9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Rest of Latin America
9.7.8.1. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
9.7.8.2. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
9.7.8.3. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
9.7.8.4. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Alivira Animal Health Limited
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. AMGIS Lifescience Ltd.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Bimeda Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Chempro Pharma Private Limited
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Excel Industries Limited
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. FIS - Fabbrica Italiana Sintetici S.p.A.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Grupo Indukern S.L.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Huateng Pharma
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Huvepharma AD
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Menadiona S.L.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. NGL Fine-Chem Ltd.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Ofichem Group B.V.
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. SUANFARMA S.A
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Zoetis Inc.
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.